Singapore Markets closed

Safeguard Scientifics, Inc. (SFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.8300-0.1100 (-2.79%)
At close: 04:00PM EDT
3.8300 -0.02 (-0.52%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.9800
52-week low 33.3200
50-day moving average 34.0704
200-day moving average 34.9528

Share statistics

Avg vol (3-month) 313k
Avg vol (10-day) 318.46k
Shares outstanding 516.51M
Implied shares outstanding 6N/A
Float 811.79M
% held by insiders 117.07%
% held by institutions 154.25%
Shares short (14 Jul 2022) 4266.37k
Short ratio (14 Jul 2022) 413.4
Short % of float (14 Jul 2022) 41.75%
Short % of shares outstanding (14 Jul 2022) 41.62%
Shares short (prior month 14 Jun 2022) 4368.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 329 Dec 2019
Ex-dividend date 419 Dec 2019
Last split factor 21:6
Last split date 326 Aug 2009

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-5.65%
Return on equity (ttm)4.29%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)2.67M
Diluted EPS (ttm)-1.8130
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.96M
Total cash per share (mrq)1.34
Total debt (mrq)1.96M
Total debt/equity (mrq)4.51
Current ratio (mrq)22.67
Book value per share (mrq)3.01

Cash flow statement

Operating cash flow (ttm)-7M
Levered free cash flow (ttm)-5.02M